Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
boston blog main
2
×
clinical trials
2
×
drugs
life sciences
national blog main
rna interference
accelerated approval
acute hepatic porphyria
alirocumab
amgen
aminolevulinic acid
biotech
boston
boston top stories
evercore isi
evolocumab
givosiran
heart attack
inclisiran
joseph swartz
medicines co.
new york
new york blog main
new york top stories
pcsk9 inhibitors
regeneron pharmaceuticals
stroke
svb leerink
umer raffat
What
alnylam
data
2
×
drug
new
pharmaceuticals
rna
2
×
based
cholesterol
cleared
evidence
far
heart
interference
lasting
long
looms
lowering
market
medco
medicine
medicines
nasdaq
ok
partner
presented
reckoning
rnai
second
seek
speedy
supporting
term
touts
use
Language
Current search:
data
×
" clinical trials "
×
" boston blog main "
×
rna
×
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug